Quince therapeutics to host investor webinar today focused on addressing the high unmet need in ataxia-telangiectasia

South san francisco, calif.--(business wire)---- $qncx #biotech--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced that it will host an investor webinar today, friday, february 7, 2025, beginning at 10:00 a.m. eastern time, featuring key opinion leader (kol) dr. mary kay koenig from uthealth houston with a discussion focused on addressing the high unmet need in ataxia-telangiectasia.
QNCX Ratings Summary
QNCX Quant Ranking